AMBS — Amarantus Bioscience Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Amarantus Bioscience Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2013 December 31st	C2014 December 31st	R2015 December 31st	2017 December 31st	2018 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-Q	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.03	0.214	0.176	0.051	0.001
Net Total Receivables	—	—	0	0.599	0.034
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.25	0.616	0.743	1.44	0.755
Net Property, Plant And Equipment	—	0.145	0.115	—	—
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1.86	2.26	11.7	10.2	3.48
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.54	6.33	16.1	28.4	31.4
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	8.54	6.33	17.2	28.4	31.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-6.68	-4.07	-5.53	-18.1	-27.9
Total Liabilities & Shareholders' Equity	1.86	2.26	11.7	10.2	3.48
Total Common Shares Outstanding
Total Preferred Shares Outstanding